Viewing Study NCT05223595


Ignite Creation Date: 2025-12-24 @ 2:05 PM
Ignite Modification Date: 2025-12-27 @ 10:45 PM
Study NCT ID: NCT05223595
Status: UNKNOWN
Last Update Posted: 2022-02-04
First Post: 2022-01-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Gentuximab in Combination With Almonertinib in EGFR Mutation-positive Metastatic NSCLC
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module